Dr. Schulz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
UT Physicians Neurocognitive Disorders
1941 E Rd, Ste 4358
Houston, TX 77054Phone+1 713-486-0500Fax+1 713-383-1435- Is this information wrong?
Summary
- Dr. Paul Schulz is a neurologist in Houston, TX and is affiliated with Memorial Hermann - Texas Medical Center. He received his medical degree from Boston University School of Medicine and has been in practice 33 years. He specializes in neurodegenerative and dementia & geriatrics and is experienced in amyotrophic lateral sclerosis, dementia, alzheimer's disease, risk management, and cognitive disorders.
Education & Training
- Baylor College of MedicineResidency, Neurology, 1985 - 1988
- Boston VA Healthcare System (Brockton-West Roxbury)Internship, Internal Medicine, 1984 - 1985
- Boston UniversityB.A., Medical Sciences and Psychology, Magna Cum Laude, 1977 - 1984
- Boston University School of MedicineClass of 1984
Certifications & Licensure
- TX State Medical License 1988 - 2024
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- “Dean’s Excellence in Teaching Award” UTHealth, 2022
- "Dean's Teaching Excellence Award" UTHealth, 2012
- "Doctor's Choice" Health and Fitness Magazine, 2009
- Join now to see all
Clinical Trials
- Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy Start of enrollment: 2015 Jul 01
- A Study Evaluating the Efficacy and Safety of Crenezumab Versus Placebo in Participants With Prodromal to Mild Alzheimer's Disease (AD). Start of enrollment: 2016 Mar 22
- A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease Start of enrollment: 2016 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- On the Optimal Diagnosis and the Evolving Role of Pimavanserin in Parkinson's Disease Psychosis.Fernando L Pagan, Paul E Schulz, Yasar Torres-Yaghi, Gregory M Pontone> ;CNS Drugs. 2024 Apr 8
- Deep learning to predict rapid progression of Alzheimer's disease from pooled clinical trials: A retrospective study.Xiaotian Ma, Madison Shyer, Kristofer Harris, Dulin Wang, Yu-Chun Hsu, Christine Farrell, Nathan Goodwin, Sahar Anjum, Sarah Dean, Xiaoqian Jiang, Yejin Kim, Avram S B...> ;PLOS Digital Health. 2024 Apr 1
- Characterizing Treatment Non-responders vs. Responders in Completed Alzheimer's Disease Clinical Trials.Dulin Wang, Yaobin Ling, Kristofer Harris, Paul E Schulz, Xiaoqian Jiang, Yejin Kim> ;Medrxiv. 2023 Oct 30
- Join now to see all
Journal Articles
- Delirious Mania in Bipolar DisorderKimm, TS, Okusaga OO, and Schulz PE, Prim Care Companion CNS Disord, 1/2/2017
- NeuropsychiatryArora G, Schulz PE, Neurology Secrets, 1/1/2017
- Hippocampal Sclerosis in Older Patients: Practical Examples and Guidance With a Focus on Cerebral Age-Related TDP-43 With SclerosisCykowski MD, Powell SZ, Schulz PE, Takei H, Rivera AL, Jackson RE, Roman G, Jicha GA, and Nelson PT, Arch Pathol Lab Med, 1/1/2017
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Deep Brain Stimulation of the Medial Forebrain Bundle: Significant Responses in Treatment Resistant Depression.Fenoy AJ, Schulz P, Selvaraj S, Burrows, Zunta-Soares G, Quevedo J, Soares JC, North American Neuromodulation Society (NANS) 21st Annual Meeting, Las Vegas, NV, 1/11/2018
- Evidence for neuroinflammation in semantic dementia.Pascual MB, Roman GC, Yu M, Pal N, Rockers ED, Fregonara Z, Funk Q, Schulz PE, and Masdeu J, Human Amyloid Imaging Conference, 1/1/2018
- Nonfluent variant of primary progressive aphasia: Tau deposition in the language network.Pascual B, Zanotti-Fregonara P, Funk Q, Rockers E, Pal N, Yu M, Spann B, Schulz P, Masdeu J, American Academy of Neurology (AAN) Meeting, 1/1/2017
- Join now to see all
Lectures
- "Lewy Body Dementia"Austin, TX - 1/25/2017
- "Update on Neuroimaging and Therapeutic Trials in Alzheimer's Disease"Austin, TX - 1/25/2017
- "Recent Advances in Diagnosing and Treating AD"University of Texas Medical Branch, Galveston, TX - 1/22/2017
- Join now to see all
Other
- "Pimavanserin for Parkinson's Disease Psychosis."Schulz PE, Webinar with Fort Worth MDs
1/31/2017 - Commenting on the radio on "It's impossible to ignore this anymore': CTE study details devastating toll on football players."Schulz PE, News Talk 710 KURV
TX - 1/26/2017 - "Young onset Dementia in David Cassidy."Schulz PE, Television Appearance on Fox26
Houston, TX - 1/23/2017 - Join now to see all
Press Mentions
- Multivitamins May Help Slow Memory Loss in Older Adults, Study Finds – the Washington PostMay 24th, 2023
- Bruce Willis Was Diagnosed Frontotemporal Dementia. What Is It? Causes, Symptoms, TreatmentsFebruary 16th, 2023
- The 5 Coolest Things on Earth This WeekJuly 7th, 2022
- Join now to see all
Grant Support
- Pilot Study--Amyloid Mediated ToxicityNational Institute On Aging1995–2000
Hospital Affiliations
- Memorial Hermann - Texas Medical CenterHouston, Texas
- University of Texas Health Science Center at HoustonHouston, Texas
External Links
- All PubMed Publicationshttps://www.ncbi.nlm.nih.gov/myncbi/1d3Rdqa1xETkm7/bibliography/public/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: